Follow
Pranas Japertas
Pranas Japertas
Architect at Gasefi
Verified email at gasefi.com
Title
Cited by
Cited by
Year
Classification analysis of P-glycoprotein substrate specificity
R Didziapetris, P Japertas, A Avdeef, A Petrauskas
Journal of drug targeting 11 (7), 391-406, 2003
3002003
Fragmental methods in the design of new compounds. Applications of the advanced algorithm builder
P Japertas, R Didziapetris, A Petrauskas
Quantitative Structure‐Activity Relationships 21 (1), 23-37, 2002
932002
Ionization-specific prediction of blood–brain permeability
K Lanevskij, P Japertas, R Didziapetris, A Petrauskas
Journal of pharmaceutical sciences 98 (1), 122-134, 2009
722009
QSAR analysis of blood–brain distribution: the influence of plasma and brain tissue binding
K Lanevskij, J Dapkunas, L Juska, P Japertas, R Didziapetris
Journal of pharmaceutical sciences 100 (6), 2147-2160, 2011
692011
Estimation of reliability of predictions and model applicability domain evaluation in the analysis of acute toxicity (LD 50)
A Sazonovas, P Japertas, R Didziapetris
SAR and QSAR in Environmental Research 21 (1-2), 127-148, 2010
642010
Classification structure-activity relations (C-SAR) in prediction of human intestinal absorption
D Zmuidinavicius, R Didziapetris, P Japertas, A Avdeef, A Petrauskas
Journal of pharmaceutical sciences 92 (3), 621-633, 2003
622003
Ionization-specific analysis of human intestinal absorption
DP Reynolds, K Lanevskij, P Japertas, R Didziapetris, A Petrauskas
Journal of pharmaceutical sciences 98 (11), 4039-4054, 2009
442009
Improving the prediction of drug disposition in the brain
K Lanevskij, P Japertas, R Didziapetris
Expert opinion on drug metabolism & toxicology 9 (4), 473-486, 2013
382013
Trainable structure–activity relationship model for virtual screening of CYP3A4 inhibition
R Didziapetris, J Dapkunas, A Sazonovas, P Japertas
Journal of computer-aided molecular design 24 (11), 891-906, 2010
372010
Progress in toxinformatics: the challenge of predicting acute toxicity
D Zmuidinavicius, P Japertas, A Petrauskas, R Didziapetris
Current Topics in Medicinal Chemistry 3 (11), 1301, 2003
372003
Fragmental methods in the analysis of biological activities of diverse compound sets
P Japertas, R Didziapetris, A Petrauskas
Mini reviews in medicinal chemistry 3 (8), 797-808, 2003
352003
Probabilistic prediction of the human CYP3A4 and CYP2D6 metabolism sites
J Dapkunas, A Sazonovas, P Japertas
Chemistry & biodiversity 6 (11), 2101-2106, 2009
222009
Aqueous acidities of primary benzenesulfonamides: Quantum chemical predictions based on density functional theory and SMD
K Aidas, K Lanevskij, R Kubilius, L Juška, D Petkevičius, P Japertas
Journal of Computational Chemistry 36 (29), 2158-2167, 2015
192015
In silico technology for identification of potentially toxic compounds in drug discovery
R Didziapetris, DP Reynolds, P Japertas, D Zmuidinavicius, A Petrauskas
Current Computer-Aided Drug Design 2 (2), 95-103, 2006
182006
Ionization‐specific QSAR models of blood–brain penetration of drugs
K Lanevskij, P Japertas, R Didziapetris, A Petrauskas
Chemistry & Biodiversity 6 (11), 2050-2054, 2009
172009
Trainable QSAR model of Ames genotoxicity
R Didziapetris, K Lanevskij, P Japertas
Toxicology Letters, S152-S153, 2008
112008
The 235th ACS National Meeting
P Japertas, A Sazonovas, R Didziapetris, A Petrauskas
New Orleans, LA, 2008
102008
Prediction of blood–brain barrier penetration by drugs
K Lanevskij, P Japertas, R Didziapetris, A Petrauskas
Drug delivery to the central nervous system, 63-83, 2010
82010
ACD/Percepta structure design engine: Virtual enumeration and screening of physchem properties for 10 (16) compounds in real time
P Japertas, K Lanevskij, A Sazonovas
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 248, 2014
42014
DMSO Solubility Prediction
P Japertas, P Maas, A Petrauskas
LogP 2004. Zurich, Switzerland, 2004
42004
The system can't perform the operation now. Try again later.
Articles 1–20